TNF-α impairs the S-G2/M cell cycle checkpoint and cyclobutane pyrimidine dimer repair in premalignant skin cells:: Role of the PI3K-Akt pathway

被引:25
作者
Faurschou, Annesofie [1 ]
Gniadecki, Robert [1 ]
Calay, Damien [1 ,2 ]
Wulf, Hans Christian [1 ]
机构
[1] Univ Copenhagen, Bispebjerg Hosp, Dept Dermatol, Copenhagen, Denmark
[2] Univ Namur, Fac Med, Dept Histol Embryol, Namur, Belgium
关键词
D O I
10.1038/jid.2008.19
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Tumor necrosis factor-alpha (TNF-alpha) is induced by UVB radiation and has been implicated in the early stages of skin carcinogenesis. Here, we show that in normal keratinocytes and the transformed keratinocyte cell lines, HaCaT and A431, TNF-alpha stimulates protein kinase B/Akt, which results in activation of the survival complex mTORC1 (mammalian target of rapamycin complex 1) and inhibition of the proapoptotic proteins Bad and Fox03a. In UVB-irradiated HaCaT cells (10-20 mJ cm(-2)), TNF-alpha increased the proportion of cycling cells and enhanced the rate of apoptosis. A significantly higher proportion of UVB-treated HaCaT cells containing unrepaired cyclobutane pyrimidine dimers (CPDs) escaped the G2/M cell cycle checkpoint in the presence of TNF-alpha (9.5 +/- 3.3 vs 4.8 +/- 2.2%). After treatment with the PI3K inhibitor LY294002, only 1.2 +/- 0.7% of CPD-containing HaCaT cells were actively cycling. TNF-alpha enhanced apoptosis less potently and did not increase the level of CPD or stimulate cell cycle progression in normal keratinocytes. Our data suggest that TNF-alpha overrides the G2/M checkpoint in premalignant skin cells and allows for some cells containing unrepaired CPD to enter the cell cycle. The effect of TNF-alpha seems to be dependent on Akt activation and may constitute a relevant mechanism enhancing mutagenesis and tumor development.
引用
收藏
页码:2069 / 2077
页数:9
相关论文
共 38 条
  • [1] Perturbations of the AKT signaling pathway in human cancer
    Altomare, DA
    Testa, JR
    [J]. ONCOGENE, 2005, 24 (50) : 7455 - 7464
  • [2] Atypical λ/ιPKC conveys 5-lipoxygenase-leukotriene B4-mediated cross-talk between phospholipase A2s regulating NF-κB activation in response to tumor necrosis factor-α and interleukin-1β
    Anthonsen, MW
    Andersen, S
    Solhaug, A
    Johansen, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) : 35344 - 35351
  • [3] Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development
    Arnott, CH
    Scott, KA
    Moore, RJ
    Robinson, SC
    Thompson, RG
    Balkwill, FR
    [J]. ONCOGENE, 2004, 23 (10) : 1902 - 1910
  • [4] Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1
    Biggs, WH
    Meisenhelder, J
    Hunter, T
    Cavenee, WK
    Arden, KC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) : 7421 - 7426
  • [5] BOUKAMP P, 1995, ONCOGENE, V11, P961
  • [6] NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE
    BOUKAMP, P
    PETRUSSEVSKA, RT
    BREITKREUTZ, D
    HORNUNG, J
    MARKHAM, A
    FUSENIG, NE
    [J]. JOURNAL OF CELL BIOLOGY, 1988, 106 (03) : 761 - 771
  • [7] Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death
    Calautti, E
    Li, J
    Saoncella, S
    Brissette, JL
    Goetinck, PF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (38) : 32856 - 32865
  • [8] NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
    Dajee, M
    Lazarov, M
    Zhang, JY
    Cai, T
    Green, CL
    Russell, AJ
    Marinkovich, MP
    Tao, SY
    Lin, Q
    Kubo, Y
    Khavari, PA
    [J]. NATURE, 2003, 421 (6923) : 639 - 643
  • [9] Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1
    Dijkers, PF
    Medema, RH
    Lammers, JWJ
    Koenderman, L
    Coffer, PJ
    [J]. CURRENT BIOLOGY, 2000, 10 (19) : 1201 - 1204
  • [10] FOXO transcription factors at the interface between longevity and tumor suppression
    Greer, EL
    Brunet, A
    [J]. ONCOGENE, 2005, 24 (50) : 7410 - 7425